Source:http://linkedlifedata.com/resource/pubmed/id/11806995
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-1-24
|
pubmed:abstractText |
The ability of factor VIIa to initiate thrombin generation and clot formation in blood from healthy donors, blood from patients with hemophilia A, and in anti-factor IX antibody-induced ("acquired") hemophilia B blood was investigated. In normal blood, both factor VIIa-tissue factor (TF) complex and factor VIIa alone initiated thrombin generation. The efficiency of factor VIIa was about 0.0001 that of the factor VIIa-TF complex. In congenital hemophilia A blood and "acquired" hemophilia B blood in vitro, addition of 10 to 50 nM factor VIIa (pharmacologic concentrations) corrected the clotting time at all TF concentrations tested (0-100 pM) but had little effect on thrombin generation. Fibrinopeptide release and insoluble clot formation were only marginally influenced by addition of factor VIIa. TF alone had a more pronounced effect on thrombin generation; an increase in TF from 0 to 100 pM increased the maximum thrombin level in "acquired" hemophilia B blood from 120 to 480 nM. Platelet activation was considerably enhanced by addition of factor VIIa to both hemophilia A blood and "acquired" hemophilia B blood. Thus, pharmacologic concentrations of factor VIIa cannot restore normal thrombin generation in hemophilia A and hemophilia B blood in vitro. The efficacy of factor VIIa (10-50 nM) in hemophilia blood is dependent on TF.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
923-30
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11806995-Adult,
pubmed-meshheading:11806995-Blood Coagulation,
pubmed-meshheading:11806995-Blood Coagulation Tests,
pubmed-meshheading:11806995-Case-Control Studies,
pubmed-meshheading:11806995-Dose-Response Relationship, Drug,
pubmed-meshheading:11806995-Factor VIIa,
pubmed-meshheading:11806995-Fibrinogen,
pubmed-meshheading:11806995-Hemophilia A,
pubmed-meshheading:11806995-Hemophilia B,
pubmed-meshheading:11806995-Humans,
pubmed-meshheading:11806995-Kinetics,
pubmed-meshheading:11806995-Male,
pubmed-meshheading:11806995-Models, Biological,
pubmed-meshheading:11806995-Thrombin,
pubmed-meshheading:11806995-Thromboplastin
|
pubmed:year |
2002
|
pubmed:articleTitle |
Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
|
pubmed:affiliation |
College of Medicine, University of Vermont, 89 Beaumont Ave, Burlington, VT 05405-0068, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|